Lab of Biochemistry & Molecular Biology, School of Life Sciences, Yunnan University, Kunming 650091, China.
Int J Mol Sci. 2024 Sep 7;25(17):9703. doi: 10.3390/ijms25179703.
Breast cancer (BC) has become the most life-threatening cancer to women worldwide, with multiple subtypes, poor prognosis, and rising mortality. The molecular heterogeneity of BC limits the efficacy and represents challenges for existing therapies, mainly due to the unpredictable clinical response, the reason for which probably lies in the interactions and alterations of diverse cell death pathways. However, most studies and drugs have focused on a single type of cell death, while the therapeutic opportunities related to other cell death pathways are often neglected. Therefore, it is critical to identify the predominant type of cell death, the transition to different cell death patterns during treatment, and the underlying regulatory mechanisms in BC. In this review, we summarize the characteristics of various forms of cell death, including PANoptosis (pyroptosis, apoptosis, necroptosis), autophagy, ferroptosis, and cuproptosis, and discuss their triggers and signaling cascades in BC, which may provide a reference for future pathogenesis research and allow for the development of novel targeted therapeutics in BC.
乳腺癌(BC)已成为全球范围内威胁女性生命健康的最主要癌症之一,其具有多种亚型、预后不良和死亡率上升等特点。BC 的分子异质性限制了其治疗效果,并为现有治疗方法带来了挑战,主要原因是其临床反应不可预测,而这可能与不同细胞死亡途径的相互作用和改变有关。然而,大多数研究和药物都集中在单一类型的细胞死亡上,而其他细胞死亡途径的治疗机会往往被忽视。因此,确定 BC 中主要的细胞死亡类型、治疗过程中向不同细胞死亡模式的转变以及潜在的调控机制至关重要。在这篇综述中,我们总结了各种形式的细胞死亡的特征,包括 PANoptosis(细胞焦亡、细胞凋亡、细胞坏死性凋亡)、自噬、铁死亡和铜死亡,并讨论了它们在 BC 中的触发因素和信号级联反应,这可能为未来的发病机制研究提供参考,并为 BC 中新型靶向治疗的开发提供依据。